Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...

UBS analyst Matthew Weston maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF338.00. The company’s shares closed yesterday at $324.00.

The news came as Roche recorded a 10% increase in first-quarter revenues to CHF 16.4 billion ($17.2 billion), on strong US demand for rapid COVID-19 antigen tests, as well as the performances of ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

“If I’m being completely transparent, in the beginning, I was a little hurt to know that it would just continue in that way,” Nieves now tells THR when opening up about her former scene partner.